Hybridoma Cell Line B6GE1, Monoclonal Antibody to the Specific Peptide-MHC Class II Complex

Description:
Hybridoma Cell Line B6GE1 as described in Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13856-61 and developed in the laboratory of Dr. Ronald Germain.
Patent Information:
For Information, Contact:
Daniel Lee
TTPS/Technology Transfer Manager
NIH Technology Transfer
301-761-6327
daniel.lee5@nih.gov
Inventors:
Ronald Germain
Keywords:
B6GE1
Cell
Hybridoma
Line
Mab
RM
WIXXXX
© 2024. All Rights Reserved. Powered by Inteum